How many institutions held SLDB - Solid Biosciences Inc. - Common Stock, $0.001 par value per share in Q3 2023?

34 institutional investors reported SLDB - Solid Biosciences Inc. - Common Stock, $0.001 par value per share for Q3 2023. Use the holders table for investor-level position and value details.

Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB)

Q: What does CUSIP 83422E204 represent in this 13F holders report?

CUSIP 83422E204 is the security identifier for SLDB - Solid Biosciences Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

CUSIP: 83422E204

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 92,783,558
Total 13F shares: 16,169,847
Share change: -170,394
Total reported value: $40,746,223
Price per share: $2.52
Number of holders: 34
Value change: -$462,509
Number of buys: 9
Number of sells: 10

Quarterly Holders Quick Answers

What is CUSIP 83422E204?
CUSIP 83422E204 identifies SLDB - Solid Biosciences Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Institutional Holders of Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) as of Q3 2023

As of 30 Sep 2023, Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,169,847 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Bain Capital Life Sciences Investors, LLC, Camber Capital Management LP, Finepoint Capital LP, Laurion Capital Management LP, Artal Group S.A., Alyeska Investment Group, L.P., GREAT POINT PARTNERS LLC, and VANGUARD GROUP INC. This page lists 34 institutional shareholders reporting positions in this security for the Q3 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.